{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:57:14Z","timestamp":1763017034415},"reference-count":37,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1253\/circj.cj-09-0858","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T22:30:19Z","timestamp":1275604219000},"page":"1436-1441","source":"Crossref","is-referenced-by-count":42,"title":["Atherosclerosis in Patients With Cyanotic Congenital Heart Disease"],"prefix":"10.1253","volume":"74","author":[{"given":"Mari&euml;lle GJ","family":"Duffels","sequence":"first","affiliation":[{"name":"Department of Cardiology, Academic Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlijn M","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Academic Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieke D","family":"Trip","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Academic Medical Center"},{"name":"Department of Vascular Medicine, Academic Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"de Groot","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Academic Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Gort","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Academic Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie PJ","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Nijmegen Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke S","family":"Hoendermis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Groningen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Daliento","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Padua"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeiko H","family":"Zwinderman","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, Academic Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf MF","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Paediatric Cardiology, University Medical Center Groningen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara JM","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Academic Medical Center"},{"name":"Department of Cardiology, University Medical Center Utrecht"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Perloff JK. The coronary circulation in cyanotic congenital heart disease. Int J Cardiol 2004; 97(Suppl 1): 79-86.","DOI":"10.1016\/j.ijcard.2004.08.018"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fyfe A, Perloff JK, Niwa K, Child JS, Miner PD. Cyanotic congenital heart disease and coronary artery atherogenesis. Am J Cardiol 2005; 96: 283-290.","DOI":"10.1016\/j.amjcard.2005.03.060"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW, et al. Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry. Int J Cardiol 2007; 120: 198-204.","DOI":"10.1016\/j.ijcard.2006.09.017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958; 46: 755-762.","DOI":"10.1136\/bmj.2.5099.755"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, et al. Eisenmenger syndrome: Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845-1855.","DOI":"10.1053\/euhj.1998.1046"},{"key":"6","unstructured":"6. Duffels MGJ, Berger RMF, Bresser P, de Bruin-Bon HACM, Hoendermis E, Bouma BJ, et al. Applicability of bosentan in Dutch patients with Eisenmenger syndrome: Preliminary results on safety and exercise capacity. Neth Heart J 2006; 14: 165-170."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. van Loon RL, Hoendermis ES, Duffels MG, Vonk-Noordegraaf A, Mulder BJ, Hillege HL, et al. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: Does the beneficial effect persist? Am Heart J 2007; 154: 776-782.","DOI":"10.1016\/j.ahj.2007.06.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease: Hematologic derangements, renal function, and urate metabolism. Cardiol Clin 1993; 11: 689-699.","DOI":"10.1016\/S0733-8651(18)30147-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 2004; 97(Suppl 1): 109-115.","DOI":"10.1016\/j.ijcard.2004.08.015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 2006; 98: 254-258.","DOI":"10.1016\/j.amjcard.2006.01.083"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Groot de E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004; 109: III-33-III-38.","DOI":"10.1161\/01.CIR.0000131516.65699.ba"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, et al. Carotid intima-media thickness and coronary atherosclerosis: Weak or strong relations? Eur Heart J 2007; 28: 398-406.","DOI":"10.1093\/eurheartj\/ehl482"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kastelein JJ, Wiegman A, de Groot E. Surrogate markers of atherosclerosis: Impact of statins. Atheroscler Suppl 2003; 4: 31-36.","DOI":"10.1016\/S1567-5688(03)00007-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: Rationale, design, and first results. Eur J Epidemiol 2005; 20: 549-557.","DOI":"10.1007\/s10654-005-4264-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Han TH, Perloff JK, Liao JC. Nitric oxide metabolism in adults with cyanotic congenital heart disease. Am J Cardiol 2007; 99: 691-695.","DOI":"10.1016\/j.amjcard.2006.10.024"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound: ARIC Investigators. Stroke 1993; 24: 1297-1304.","DOI":"10.1161\/01.STR.24.9.1297"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Juonala M, Kahonen M, Laitinen T, Hutri-Kahonen N, Jokinen E, Taittonen L, et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: The Cardiovascular Risk in Young Finns Study. Eur Heart J 2008; 29: 1198-1206.","DOI":"10.1093\/eurheartj\/ehm556"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized controlled clinical trial. Ann Intern Med 1996; 124: 548-556.","DOI":"10.7326\/0003-4819-124-6-199603150-00002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rosove MH, Perloff JK, Hocking WG, Child JS, Canobbio MM, Skorton DJ. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 1986; 2: 313-315.","DOI":"10.1016\/S0140-6736(86)90005-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Madhavan M, Wattigney WA, Srinivasan SR, Berenson GS. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 1997; 131: 107-113.","DOI":"10.1016\/S0021-9150(97)06088-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rich MW. Uric acid: Is it a risk factor for cardiovascular disease? Am J Cardiol 2000; 85: 1018-1021.","DOI":"10.1016\/S0002-9149(99)00922-4"},{"key":"22","unstructured":"22. Wallace RB, Hunninghake DB, Reiland S, Barrett-Connor E, Mackenthun A, Hoover J, et al. Alterations of plasma high-density lipoprotein cholesterol levels associated with consumption of selected medications: The Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62: IV-77-IV-82."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Madu EC, Reddy RC, Madu AN, Anyaogu C, Harris T, Fraker TD Jr. The effects of antihypertensive agents on serum lipids. Am J Med Sci 1996; 312: 76-84.","DOI":"10.1016\/S0002-9629(15)41760-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Norozi K, Buchhorn R, Wessel A, Bahlmann J, Raab B, Geyer S, et al. Beta-blockade does not alter plasma cytokine concentrations and ventricular function in young adults with right ventricular dysfunction secondary to operated congenital heart disease. Circ J 2008; 72: 747-752.","DOI":"10.1253\/circj.72.747"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, et al. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 2002; 105: 290-292.","DOI":"10.1161\/hc0302.103711"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004; 305: 869-872.","DOI":"10.1126\/science.1099870"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Levine RF, Eldor A, Shoff PK, Kirwin S, Tenza D, Cramer EM. Circulating megakaryocytes: Delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur J Haematol 1993; 51: 233-246.","DOI":"10.1111\/j.1600-0609.1993.tb00637.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Geddis AE, Kaushansky K. Immunology. The root of platelet production. Science 2007; 317: 1689-1691.","DOI":"10.1126\/science.1148946"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kajimoto H, Nakazawa M, Murasaki K, Mori Y, Tanoue K, Kasanuki H, et al. Increased thrombogenesity in patients with cyanotic congenital heart disease. Circ J 2007; 71: 948-953.","DOI":"10.1253\/circj.71.948"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kajimoto H, Nakazawa M, Murasaki K, Hagiwara N, Nakanishi T. Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients. Circ J 2009; 73: 1705-1710.","DOI":"10.1253\/circj.CJ-08-1087"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Horigome H, Murakami T, Isobe T, Nagasawa T, Matsui A. Soluble P-selectin and thrombomodulin-protein C-protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. Thromb Res 2003; 112: 223-227.","DOI":"10.1016\/j.thromres.2003.12.011"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. DeFilippis AP, Law K, Curtin S, Eckman JR. Blood is thicker than water: The management of hyperviscosity in adults with cyanotic heart disease. Cardiol Rev 2007; 15: 31-34.","DOI":"10.1097\/01.crd.0000214959.82120.97"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic congenital heart disease: Hematologic management. Ann Intern Med 1988; 109: 406-413.","DOI":"10.7326\/0003-4819-109-5-406"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilen U, et al. The spectrum of adult congenital heart disease in Europe: Morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005; 26: 2325-2333.","DOI":"10.1093\/eurheartj\/ehi396"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996; 28: 768-772.","DOI":"10.1016\/0735-1097(96)00196-9"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation 1993; 87: 1954-1959.","DOI":"10.1161\/01.CIR.87.6.1954"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Juonala M, Kahonen M, Laitinen T, Hutri-Kahonen N, Jokinen E, Taittonen L, et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: The Cardiovascular Risk in Young Finns Study. Eur Heart J 2008; 29: 1198-1206.","DOI":"10.1093\/eurheartj\/ehm556"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/7\/74_CJ-09-0858\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:22:52Z","timestamp":1559146972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/7\/74_CJ-09-0858\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-09-0858","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}